United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news FitzWalter Capital escalates ATG takeover pressure with public rebuke over board strategy and I&C disposal FitzWalter Capital challenges ATG’s board over asset sale plan and failed M&A record. Read what this takeover tension means for investors and industry direction. byVenkateshJanuary 15, 2026